Novelion Therapeutics (NVLN) Stock: Gaining On Licensing Agreement News
Novelion Therapeutics Inc (NASDAQ: NVLN) is having a great start to the trading session this morning, and for good reason. The company announced that its subsidiary has entered into a licensing agreement, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The licensing agreement; what we’re seeing from … Read more